高级检索
当前位置: 首页 > 详情页

AMPK2 Protects Against the Development of Heart Failure by Enhancing Mitophagy via PINK1 Phosphorylation

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Huazhong Univ Sci & Technol, Div Cardiol, Dept Internal Med, Wuhan, Hubei, Peoples R China; [2]Huazhong Univ Sci & Technol,Gene Therapy Ctr,Tongji Hosp,Tongji Med Coll,Wuhan,Hubei,Peoples R China; [3]Huazhong Univ Sci & Technol, Hubei Key Lab Genet & Mol Mech Cardiol Disorders, Wuhan, Hubei, Peoples R China; [4]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Rheumatol & Immunol,Wuhan,Hubei,Peoples R China; [5]Georgia State Univ, Ctr Mol & Translat Med, Atlanta, GA USA; [6]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Internal Med,Wuhan 430030,Hubei,Peoples R China
出处:
ISSN:

关键词: autophagy constriction heart failure mice mitochondria

摘要:
Rationale: Mitochondrial dysfunction plays an important role in heart failure (HF). However, the molecular mechanisms regulating mitochondrial functions via selective mitochondrial autophagy (mitophagy) are poorly understood. Objective: We sought to determine the role of AMPK (AMP-activated protein kinase) in selective mitophagy during HF. Methods and Results: An isoform shift from AMPK2 to AMPK1 was observed in failing heart samples from HF patients and transverse aortic constriction-induced mice, accompanied by decreased mitophagy and mitochondrial function. The recombinant adeno-associated virus Serotype 9-mediated overexpression of AMPK2 in mouse hearts prevented the development of transverse aortic constriction-induced chronic HF by increasing mitophagy and improving mitochondrial function. In contrast, AMPK2(-/-) mutant mice exhibited an exacerbation of the early progression of transverse aortic constriction-induced HF via decreases in cardiac mitophagy. In isolated adult mouse cardiomyocytes, AMPK2 overexpression mechanistically rescued the impairment of mitophagy after phenylephrine stimulation for 24 hours. Genetic knockdown of AMPK2, but not AMPK1, by short interfering RNA suppressed the early phase (6 hours) of phenylephrine-induced compensatory increases in mitophagy. Furthermore, AMPK2 specifically interacted with phosphorylated PINK1 (PTEN-induced putative kinase 1) at Ser495 after phenylephrine stimulation. Subsequently, phosphorylated PINK1 recruited the E3 ubiquitin ligase, Parkin, to depolarized mitochondria, and then enhanced the role of the PINK1-Parkin-SQSTM1 (sequestosome-1) pathway involved in cardiac mitophagy. This increase in cardiac mitophagy was accompanied by the elimination of damaged mitochondria, improvement in mitochondrial function, decrease in reactive oxygen species production, and apoptosis of cardiomyocytes. Finally, Ala mutation of PINK1 at Ser495 partially suppressed AMPK2 overexpression-induced mitophagy and improvement of mitochondrial function in phenylephrine-stimulated cardiomyocytes, whereas Asp (phosphorylation mimic) mutation promoted mitophagy after phenylephrine stimulation. Conclusions: In failing hearts, the dominant AMPK isoform switched from AMPK2 to AMPK1, which accelerated HF. The results show that phosphorylation of Ser495 in PINK1 by AMPK2 was essential for efficient mitophagy to prevent the progression of HF.

基金:

基金编号: 81630010 91439203 31571197 2012CB518004 2015ZDTD044 HL079584 HL080499 HL089920 HL110488 CA213022 AG047776 HL128014 HL132500 HL137371 R01CA213022 R01HL080499 R01HL089920 R01HL137371 R01HL074399 R01HL079584 R01HL110488 R01HL132500 R01HL128014 R01HL140954 R01AG047776

语种:
高被引:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 1 区 医学
小类 | 1 区 心脏和心血管系统 1 区 血液学 1 区 外周血管病
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 心脏和心血管系统 1 区 血液学 1 区 外周血管病
JCR分区:
出版当年[2016]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Q1 HEMATOLOGY Q1 PERIPHERAL VASCULAR DISEASE
最新[2023]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Q1 HEMATOLOGY Q1 PERIPHERAL VASCULAR DISEASE

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者单位: [1]Huazhong Univ Sci & Technol, Div Cardiol, Dept Internal Med, Wuhan, Hubei, Peoples R China; [2]Huazhong Univ Sci & Technol,Gene Therapy Ctr,Tongji Hosp,Tongji Med Coll,Wuhan,Hubei,Peoples R China; [3]Huazhong Univ Sci & Technol, Hubei Key Lab Genet & Mol Mech Cardiol Disorders, Wuhan, Hubei, Peoples R China; [4]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Rheumatol & Immunol,Wuhan,Hubei,Peoples R China;
通讯作者:
通讯机构: [1]Huazhong Univ Sci & Technol, Div Cardiol, Dept Internal Med, Wuhan, Hubei, Peoples R China; [2]Huazhong Univ Sci & Technol,Gene Therapy Ctr,Tongji Hosp,Tongji Med Coll,Wuhan,Hubei,Peoples R China; [3]Huazhong Univ Sci & Technol, Hubei Key Lab Genet & Mol Mech Cardiol Disorders, Wuhan, Hubei, Peoples R China; [6]Huazhong Univ Sci & Technol,Tongji Hosp,Tongji Med Coll,Dept Internal Med,Wuhan 430030,Hubei,Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:2 总访问量:410 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)